This grant opportunity focuses on preclinical drug discovery and does not cover IND-enabling studies, manufacturing scale-up, or clinical research and development. It encourages collaborative team efforts involving experts from computational sciences, biology, and psychiatric diseases. The use of AI and its subsets, including machine learning, deep learning, neural networks, and natural language processing, is also promoted.

The focus of this NOSI is on preclinical drug discovery. Investigational New Drug (IND)-enabling studies, scale-up for manufacturing, and clinical research and development are out of the scope of this NOSI. Team science approaches where the strength and knowledge of multiple individuals across c… Show More